In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson, the plaintiffs successfully overcame a motion to dismiss. At the heart of ...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Northern Irelands Tom McKibbin claimed the last of the 10 PGA Tour cards on offer via the Race to Dubai rankings and will ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

On November 13, 2024, Amgen filed a BPCIA complaint in the District Court for the Eastern District of North Carolina against Accord Biopharma, Inc.; Accord Healthcare, Inc.; and Intas Pharmaceuticals, ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Welcome to The Hill’s Business & Economy newsletter{beacon} Business & Economy Business & Economy   The Big Story Pharma stocks sink after RFK Jr. tapped to lead ...